BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18001258)

  • 1. The latest options and future agents for treating male hypogonadism.
    Edelstein D; Sivanandy M; Shahani S; Basaria S
    Expert Opin Pharmacother; 2007 Dec; 8(17):2991-3008. PubMed ID: 18001258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging drugs for hypogonadism.
    Edelstein D; Dobs A; Basaria S
    Expert Opin Emerg Drugs; 2006 Nov; 11(4):685-707. PubMed ID: 17064226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging medication for the treatment of male hypogonadism.
    Aydogdu A; Swerdloff RS
    Expert Opin Emerg Drugs; 2016 Sep; 21(3):255-66. PubMed ID: 27552127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current topics in testosterone replacement of hypogonadal men.
    Nieschlag E
    Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):77-90. PubMed ID: 25617174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone therapy--what, when and to whom?
    Jockenhövel F
    Aging Male; 2004 Dec; 7(4):319-24. PubMed ID: 15799128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in male hormone substitution therapy.
    Qoubaitary A; Swerdloff RS; Wang C
    Expert Opin Pharmacother; 2005 Aug; 6(9):1493-506. PubMed ID: 16086637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone administration in older men.
    Matsumoto AM
    Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone undecanoate in the treatment of male hypogonadism.
    Edelstein D; Basaria S
    Expert Opin Pharmacother; 2010 Aug; 11(12):2095-106. PubMed ID: 20642374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebido: a long-acting injectable testosterone for the treatment of male hypogonadism.
    Harle L; Basaria S; Dobs AS
    Expert Opin Pharmacother; 2005 Aug; 6(10):1751-9. PubMed ID: 16086661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen replacement in men with hypogonadism and erectile dysfunction.
    Albrecht-Betancourt M; Hijazi RA; Cunningham GR
    Endocrine; 2004; 23(2-3):143-8. PubMed ID: 15146093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based medicine update on testosterone replacement therapy (TRT) in male hypogonadism: focus on new formulations.
    Giagulli VA; Triggiani V; Corona G; Carbone D; Licchelli B; Tafaro E; Resta F; SabbĂ  C; Maggi M; Guastamacchia E
    Curr Pharm Des; 2011; 17(15):1500-11. PubMed ID: 21521164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone deficiency and replacement.
    Howell S; Shalet S
    Horm Res; 2001; 56 Suppl 1():86-92. PubMed ID: 11786693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of Testim gel.
    McNicholas T; Ong T
    Expert Opin Pharmacother; 2006 Mar; 7(4):477-84. PubMed ID: 16503819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new testosterone gel (fortesta) for hypogonadism.
    Med Lett Drugs Ther; 2011 Apr; 53(1362):29-30. PubMed ID: 21502933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone replacement therapy in male hypogonadism.
    Byrne M; Nieschlag E
    J Endocrinol Invest; 2003 May; 26(5):481-9. PubMed ID: 12906378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypogonadism in Male Infants and Adolescents: New Androgen Formulations.
    Chioma L; Cappa M
    Horm Res Paediatr; 2023; 96(6):581-589. PubMed ID: 34915486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone replacement therapy for male hypogonadism: part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents.
    Seftel A
    Int J Impot Res; 2007; 19(1):2-24. PubMed ID: 16193074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Therapy for Male Hypogonadism.
    Carrasquillo R; Chu K; Ramasamy R
    Curr Urol Rep; 2018 Jun; 19(8):63. PubMed ID: 29886559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
    Johansen KL
    Semin Dial; 2004; 17(3):202-8. PubMed ID: 15144546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy.
    Ide V; Vanderschueren D; Antonio L
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.